Retaglutide is a novel GLP-1 receptor agonist currently under research for the treatment of obesity. This medication works by mimicking the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring hormone that https://hassanqobk234466.theideasblog.com/39505245/trelaglutide-exploring-a-new-treatment-for-chronic-diseases